NYSE:CLX - New York Stock Exchange, Inc. - US1890541097 - Common Stock - Currency: USD
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
/PRNewswire/ -- DiGiorno® and Hidden Valley® Ranch know that pizza and ranch isn't just a pairing, it's a lifestyle. That is why they are teaming up to take...
/PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.22 per share on the...
CLX faces near-term pressure from weak earnings and ongoing operational transitions, but its long-term strategy bodes well.
Kraft-Heinz stock hit bottom in early 2025 as institutional activity ramped to a multi-year high, netting 1% of the market cap in the first two months.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how household products stocks fared in Q4, starting with Central Garden & Pet (NASDAQ:CENT).
Looking back on household products stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Clorox (NYSE:CLX) and its peers.
With recent volatility in the stock market due to trade tariff announcements, analysts seem to have picked three stocks to boost today.
/PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle, Chief Financial Officer Kevin Jacobsen and...
Shares of consumer products giant Clorox (NYSE:CLX) fell 7% in the afternoon session after the company reported underwhelming fourth quarter results, with revenue down 15%, reflecting inventory normalization and the sale of the Better Health Vitamins, Minerals & Supplements (VMS) and Argentina businesses. This marks a sharp reversal from the 16% growth a year ago. The previous year's numbers got a temporary lift when Clorox restocked stores after the August 2023 cyberattack. That boost didn't re